Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 4, 2009, Pages 370-379

  Ribeiro, Rosane A ^a   Bonfleur, Maria L ^b   Amaral, Andressa G ^a   Vanzela, Emerielle C ^a   Rocco, Silvana A ^a   Boschero, Antonio C ^a   Carneiro, Everardo M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

Author keywords

Glucose homeostasis; Insulin secretion; Taurine supplementation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM 45; CALCIUM CHANNEL L TYPE; CALCIUM ION; DRINKING WATER; GLUCAGON; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; LEUCINE; TAURINE; CALCIUM; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; GLUCAGON RELEASE; GLUCOSE OXIDATION; GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; SECRETION;

ANIMALS; BLOOD GLUCOSE; CALCIUM; CALCIUM CHANNELS, L-TYPE; DIETARY SUPPLEMENTS; GLUCAGON; INSULIN; ISLETS OF LANGERHANS; LEUCINE; MICE; TAURINE;

EID: 69249232232     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.959     Document Type: Article

References (58)

1. Straub SG, Sharp GW. Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes Metab Res Rev 2002; 18: 451-463.
2. Newsholme P, Bender K, Kiely A, Brennan L. Amino acid metabolism, insulin secretion and diabetes. Biochem Soc Trans 2007; 35: 1180-1186.
3. Bustamante J, Lobo MV, Alonso FJ, et al. An osmotic-sensitive taurine pool is localized in rat pancreatic islet cells containing glucagon and somatostatin. Am J Physiol Endocrinol Metab 2001; 281: E1275-E1285.
4. Schaffer S, Takahashi K, Azuma J. Role of osmoregulation in the actions of taurine. Amino Acids 2000; 19: 527-546.
5. Satoh H. Cardiac actions of taurine as a modulator of the ion channels. Adv Exp Med Biol 1998; 442: 121-128.
6. 2+ sequestration by taurine. Biochem Pharmacol 1999; 58: 1123-1131.
7. Foos TM, Wu JY. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem Res 2002; 27: 21-26.
8. + channels by taurine through a benzamido-binding site on sulfonylurea receptor 1. Biochem Pharmacol 2004; 67: 1089-1096.
9. Lee SH, Lee HY, Kim SY, Lee IK, Song DK. Enhancing effect of taurine on glucose response in UCP2-overexpressing beta cells. Diabetes Res Clin Pract 2004; 66(Suppl 1): S69-S74.
10. + channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes. Biochem Pharmacol 2004; 68: 901-910.
11. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992; 72: 101-163.
12. Tas S, Sarandol E, Ayvalik SZ, Serdar Z, Dirican M. Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems. Arch Med Res 2007; 38: 276-283.
13. Moran J, Salazar P, Pasantes-Morales H. Effect of tocopherol and taurine on membrane fluidity of retinal rod outer segments. Exp Eye Res 1987; 45: 769-776.
14. Kulakowski EC, Maturo J. Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 1984; 33: 2835-2838.
15. Maturo J, Kulakowski EC. Taurine binding to the purified insulin receptor. Biochem Pharmacol 1988; 37: 3755-3760.
16. Kaplan B, Karabay G, Zagyapan RD, et al. Effects of taurine in glucose and taurine administration. Amino Acids 2004; 27: 327-333.
17. Cherif H, Reusens B, Ahn MT, Hoet JJ, Remacle C. Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol 1998; 159: 341-348.
18. Nandhini AT, Thirunavukkarasu V, Ravichandran MK, Anuradha CV. Effect of taurine on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats. Singapore Med J 2005; 46: 82-87.
19. Tsuboyama-Kasaoka N, Shozawa C, Sano K, et al. Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 2006; 147: 3276-3284.
20. Arany E, Strutt B, Romanus P, et al. Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice. Diabetologia 2004; 47: 1831-1837.
21. Boujendar S, Reusens B, Merezak S, et al. Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia 2002; 45: 856-866.
22. Kaniuk NA, Kiraly M, Bates H, et al. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 2007; 56: 930-939.
23. Xiao C, Giacca A, Lewis GF. Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. Diabetologia 2008; 51: 139-146.
24. Cherif H, Reusens B, Dahri S, Remacle C, Hoet JJ. Stimulatory effects of taurine on insulin secretion by fetal rat islets cultured in vitro. J Endocrinol 1996; 151: 501-506.
25. Carneiro EM, Latorraca MQ, Araujo E, et al. Taurine supplementation modulates glucose homeostasis and islet function. J Nutr Biochem 2008, in press.
26. Bonora E, Manicardi V, Zavaroni I, Coscelli C, Butturini U. Relationships between insulin secretion, insulin metabolism and insulin resistance in mild glucose intolerance. Diabete Metab 1987; 13: 116-121.
27. Bordin S, Boschero AC, Carneiro EM, Atwater I. Ionic mechanisms involved in the regulation of insulin secretion by muscarinic agonists. J Membr Biol 1995; 148: 177-184.
28. Hoy M, Bokvist K, Xiao-Gang W, et al. Phentolamine inhibits exocytosis of glucagon by Gi2 protein-dependent activation of calcineurin in rat pancreatic alpha cells. J Biol Chem 2001; 276: 924-930.
29. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
30. Kawamoto Y, Shinozuka K, Kunitomo M, Haginaka J. Determination of ATP and its metabolites released from rat caudal artery by isocratic ion-pair reversed-phase high-performance liquid chromatography. Anal Biochem 1998; 262: 33-38.
31. Katayama M, Matsuda Y, Shimokawa K, et al. Simultaneous determination of six adenyl purines in human plasma by high-performance liquid chromatography with fluorescence derivatization. J Chromatogr B Biomed Sci Appl 2001; 760: 159-163.
32. Amaral ME, Ueno M, Carvalheira JB, et al. Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway. Horm Metab Res 2003; 35: 282-289.
33. Sener A, Malaisse WJ. L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 1980; 288: 187-189.
34. Loizzo A, Carta S, Bennardini F, et al. Neonatal taurine administration modifies metabolic programming in male mice. Early Hum Dev 2007; 83: 693-696.
35. Anuradha CV, Balakrishnan SD. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 1999; 77: 749-754.
36. Nakaya Y, Minami A, Harada N, et al. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 2000; 71: 54-58.
37. Nandhini AT, Anuradha CV. Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats. Amino Acids 2002; 22: 27-38.
38. Barg S. Mechanisms of exocytosis in insulin-secreting B-cells and glucagon-secreting A-cells. Pharmacol Toxicol 2003; 92: 3-13.
39. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 2007; 28: 84-116.
40. 2+ channels. J Biol Chem 1995; 270: 30 036-30 044.
41. Yang SN, Berggren PO. The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology. Endocr Rev 2006; 27: 621-676.
42. Iwashima Y, Pugh W, Depaoli AM, et al. Expression of calcium channel mRNAs in rat pancreatic islets and downregulation after glucose infusion. Diabetes 1993; 42: 948-955.
43. Safayhi H, Haase H, Kramer U, et al. L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells. Mol Endocrinol 1997; 11: 619-629.
44. Iwashima Y, Abiko A, Ushikubi F, et al. Downregulation of the voltage-dependent calcium channel (VDCC) beta-subunit mRNAs in pancreatic islets of type 2 diabetic rats. Biochem Biophys Res Commun 2001; 280: 923-932.
45. 2+ oscillation frequency and insulin exocytosis. Cell 2004; 119: 273-284.
46. Ihara Y, Yamada Y, Fujii Y, et al. Molecular diversity and functional characterization of voltage-dependent calcium channels (CACN4) expressed in pancreatic beta-cells. Mol Endocrinol 1995; 9: 121-130.
47. Kawai K, Yokota C, Ohashi S, Watanabe Y, Yamashita K. Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Diabetologia 1995; 38: 274-276.
48. Cabrera O, Berman DM, Kenyon NS, et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 2006; 103: 2334-2339.
49. Moens K, Heimberg H, Flamez D, et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 1996; 45: 257-261.
50. Moens K, Flamez D, Van Schravendijk C, et al. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors. Diabetes 1998; 47: 66-72.
51. Huypens P, Ling Z, Pipeleers D, Schuit F. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 2000; 43: 1012-1019.
52. 2+. J Gen Physiol 2004; 124: 653-662.
53. Hatakeyama H, Kishimoto T, Nemoto T, Kasai H, Takahashi N. Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets. J Physiol 2006; 570: 271-282.
54. 2+ release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic beta-cells. J Biol Chem 2004; 279: 45 455-45 461.
55. 26+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 1997; 19: 185-196.
56. 2+ channels. Journal of Receptors and Signal Transduction 2005; 25: 57-71.
57. ATP channel-independent signaling pathway by the nonhydrolyzable analog of leucine, BCH. Am J Physiol Endocrinol Metab 2003; 285: E380-E389.
58. Macdonald MJ, Hasan NM, Longacre MJ. Studies with leucine, beta-hydroxybutyrate and ATP citrate lyase-deficient beta cells support the acetoacetate pathway of insulin secretion. Biochim Biophys Acta 2008; 1780: 966-972.